Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

ACON vs SVRE: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ACON Wins Head-to-Head Institutional Verdict (3–1 across 6 Pillars · 4–1 Matrix Metrics)

ACON Overall Winner 6-Pillar Tally: ACON 3 – 1 SVRE (2 Tie) Matrix Metrics: ACON 4 – 1 SVRE

As of Nov 17, 2026, Aclarion, Inc. (ACON) is the stronger overall head-to-head candidate over SaverOne 2014 Ltd. (SVRE) in the Tradestie Institutional Equity Comparison Engine, winning 4–1 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). ACON carries a Unified Composite Score of 39.3/100 (SELL) at $1.43 (N/M Forward P/E, -10789.2% operating margin), whereas SVRE carries 39.3/100 (SELL) at $0.43 (N/M Forward P/E, 0.0% operating margin).

  • Defensive Composite Rating Caution: Although ACON compares more favorably head-to-head, both ACON (39.3/100 SELL) and SVRE (39.3/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: ACON is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.7); meanwhile SVRE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ACON vs SVRE
ACON NASDAQ Head-to-Head Winner
Aclarion, Inc. Common Stock
Services-Medical Laboratories
$1.43
+2.88% 1D
Market Cap $4.5M
TTM Revenue $98,560
Forward P/E N/M
Beta / 30D Vol 1.28β · 78% Vol
Unified Composite Score
39.3 / 100 SELL
Tech 25.0 Fund 46.0 Flow 50.0 Mom 59.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -11.4%), weak momentum, RSI 28
RSI-14: 27.7 · SMA20: $1.78 · SMA50: $2.15
SVRE NASDAQ
SaverOne 2014 Ltd. American Depositary Shares
Services-Computer Programming Services
$0.43
-1.46% 1D
Market Cap $1.1M
TTM Revenue $2.0M
Forward P/E N/M
Beta / 30D Vol 0.49β · 190% Vol
Unified Composite Score
39.3 / 100 SELL
Tech 25.0 Fund 46.0 Flow 50.0 Mom 59.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -36.4%), weak momentum, RSI 28
RSI-14: 28.4 · SMA20: $0.89 · SMA50: $1.47

6-Pillar Scorecard Institutional Category Breakdown (ACON 3 – 1 SVRE)

Columns: Metric · ACON · SVRE
1. Valuation Multiples SVRE
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 45.6x 0.6x
2. Growth & Scale ACON
Revenue Growth (YoY) +78.1% -63.0%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $98,560 $2.0M
Market Cap $4.5M $1.1M
3. Profitability & Quality ACON
Gross Margin 29.1% -41.1%
Operating Margin -10789.2% 0.0%
Net Profit Margin 0.0% 0.0%
Return on Equity (ROE) -74.1% -151.1%
4. Balance Sheet & Cash Flow ACON
Cash Generation (TTM) -$7.5M -$34M EBITDA
Cash Flow Margin N/A N/A
Net Cash / Leverage $5.13 Book/Sh · -74.1% ROE $0.00 Book/Sh · -151.1% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Health Information Services Operator Scientific & Technical Instruments Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ACON (4) vs SVRE (1)
Institutional Metric ACON SVRE Criterion Row Edge
Market Capitalization
Scale
$4.5M $1.1M Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+78.1% -63.0% Higher Growth ACON
Operating Margin (TTM)
Profitability
-10789.2% 0.0% Higher Margin SVRE
Net Profit Margin
Profitability
0.0% 0.0% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
-74.1% -151.1% Higher ROE ACON
52-Week Range Position
Momentum
1% ($1–$9) 0% ($0–$6) Stronger Trend ACON
Beta / 30D Volatility
Risk Regime
1.28β · 78% Vol 0.49β · 190% Vol Lower Realized Risk ACON
Unified Institutional Score
Composite Signal
39.3 / 100 (SELL) 39.3 / 100 (SELL) Higher Composite Tie
Trailing 12M Revenue (USD)
Operating Scale
$98,560 $2.0M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
29.1% -41.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 45.6x EV/Rev N/M PEG · 0.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$7.5M ($5.13 Book/Sh · -74.1% ROE) -$34M EBITDA ($0.00 Book/Sh · -151.1% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ACON +51.91 pp
ACON: -24.34% · SVRE: -76.25%
3M Horizon ACON +36.7 pp
ACON: -48.38% · SVRE: -85.08%
6M Horizon ACON +34.24 pp
ACON: -55.31% · SVRE: -89.55%
1Y Horizon SVRE +20.13 pp
ACON: -76.79% · SVRE: -56.66%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ACON vs SVRE. Trailing 12-month operating profitability (ACON -10789.2% vs SVRE 0.0%) and valuation multiples (ACON N/M vs SVRE N/M Forward P/E) are benchmarked directly in Pillar 4 below.

ACON ADR TTM Benchmark FX-Normalized USD
TTM Revenue$98,560
Gross Margin29.1%
Op. Margin-10789.2%
ROE / Fwd P/E-74.1% · N/M
SVRE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$2.0M
Gross Margin-41.1%
Op. Margin0.0%
ROE / Fwd P/E-151.1% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ACON UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ACON Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SVRE UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew Thin ADR Chain
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SVRE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ACON Moat Profile Cyclical / Execution-Driven Positioning
Health Information Services Operator
Competes within the Health Information Services value chain with $4.5M market capitalization and -10789.2% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
SVRE Moat Profile Cyclical / Execution-Driven Positioning
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $1.1M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ ACON vs SVRE Key Questions & Quantitative Answers

As of Nov 17, 2026, Aclarion, Inc. (ACON) is the stronger overall head-to-head candidate over SaverOne 2014 Ltd. (SVRE) in the Tradestie Institutional Equity Comparison Engine, winning 4–1 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). ACON carries a Unified Composite Score of 39.3/100 (SELL) at $1.43 (N/M Forward P/E, -10789.2% operating margin), whereas SVRE carries 39.3/100 (SELL) at $0.43 (N/M Forward P/E, 0.0% operating margin). Defensive Composite Rating Caution: Although ACON compares more favorably head-to-head, both ACON (39.3/100 SELL) and SVRE (39.3/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: ACON is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.7); meanwhile SVRE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ACON leads the Growth & Scale pillar: ACON posts +78.1% YoY revenue growth and +0.0% YoY earnings growth on $98,560 TTM revenue (29.1% gross margin, -10789.2% operating margin), compared with SVRE at -63.0% YoY revenue growth and +0.0% YoY earnings growth on $2.0M TTM revenue (-41.1% gross margin, 0.0% operating margin). On trailing 12-month operating scale, ACON generates $98,560 in USD-normalized revenue versus $2.0M for SVRE. In operating R&D and SG&A reinvestment, ACON deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for SVRE.

SVRE screens cheaper on headline valuation multiples. ACON trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 45.6x EV/Revenue (unreported FCF margin), whereas SVRE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.6x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ACON (-74.1% ROE) versus SVRE (-151.1% ROE) capital efficiency.

In options market volatility and institutional positioning, ACON carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.28β · 78% Vol realized risk). By comparison, SVRE carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.49β · 190% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.